Cite
P3-062: CALPAIN-1 IN NEURODEGENERATION: EVALUATING THERAPEUTIC EFFICACY OF INHIBITION STRATEGIES
MLA
Gregory R. J. Thatcher, et al. “P3-062: Calpain-1 in Neurodegeneration: Evaluating Therapeutic Efficacy of Inhibition Strategies.” Alzheimer’s & Dementia, vol. 15, July 2019, p. P949. EBSCOhost, https://doi.org/10.1016/j.jalz.2019.06.3089.
APA
Gregory R. J. Thatcher, Rachel C. Knopp, Leon M. Tai, Oleksii Dubrovskyi, Ammar Jastinah, & Sue H. Lee. (2019). P3-062: Calpain-1 in Neurodegeneration: Evaluating Therapeutic Efficacy of Inhibition Strategies. Alzheimer’s & Dementia, 15, P949. https://doi.org/10.1016/j.jalz.2019.06.3089
Chicago
Gregory R. J. Thatcher, Rachel C. Knopp, Leon M. Tai, Oleksii Dubrovskyi, Ammar Jastinah, and Sue H. Lee. 2019. “P3-062: Calpain-1 in Neurodegeneration: Evaluating Therapeutic Efficacy of Inhibition Strategies.” Alzheimer’s & Dementia 15 (July): P949. doi:10.1016/j.jalz.2019.06.3089.